Kick Off: CSL Limited v ResMed. Inc

The healthcare group is a strong one, as two of the ASX's best teams go head to head.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Welcome to this ASX World Cup group game between CSL Limited (ASX: CSL) and ResMed. Inc (CHESS) (ASX: RMD). It might be the healthcare group, but given the strength of the teams also including Ramsay Health Care Limited (ASX: RHC) and Sonic Healthcare Limited (ASX: SHL) it looks more like the group of death. Whoever gets out of this group could present a strong challenge for the tournament winner.

Pre-match commentary and stats

Blood plasma product manufacturer CSL has been a star performer over the past five years, up 113.79% compared to the S&P/ASX 200 Index's (INDEXASX:XJO) handy 38.9% rise. Meanwhile sleep disorder business ResMed has risen around 78% since June 2012. But which is the stronger outfit on current valuations? 

CSL Limited ResMed
Code ASX:CSL ASX:RMD
Recent Price $67.45 $5.52
Market Capitalisation $32.25 billion $7.8 billion
Dividend Yield / Franking 1.8% | 0% 1.7% | 0%
Projected P/E ratio 2015 19.4 19.2
Price-Book ratio 10.14 4.6

Source: Thomson Consensus Estimates

The match kicks off with both teams looking quite evenly matched in terms of forward price-earnings ratios suggesting the market rates both these businesses for their potential to keep on growing. Both have an almost perfect track record of steadily growing revenues, but CSL's greater diversity of geographic sales reach means it takes an early lead 1-0. ResMed is heavily reliant on the U.S market, where it has faced challenging conditions recently.

Half time and it's 1-0 to CSL.

Central to both businesses strong recent performance has been gross margin expansion ahead of expectations, ResMed benefits from a gradually falling Australian dollar and CSL from the operating leverage provided by the critical nature of its life-saving blood plasma products. CSL's oligopolistic position is hard to beat and it takes a 2-0 lead.

Both businesses also have experienced management teams and strong track records of innovation and new product delivery. However, ResMed's conveyor belt of new products and strong commitment to research demonstrated by its reported attempts to recruit the best science graduates from Australian universities means chief executive Mick Farrell scores a Tim Cahill like volley to pull one goal back, but it's not enough and CSL runs out a 2-1 winner! If you prefer your stocks to deliver more income, then there's one we know with…

Motley Fool contributor Tom Richardson owns shares in ResMed Inc. You can find him on Twitter @tommyr345

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »